Shenzhen Beike BioTech
Member
Shenzhen Beike Biotechnology Co., Ltd. (Beike Biotechnology) is a leading Chinese biotechnology company based in Shenzhen China. Beike Biotechnology specializes in research, clinical translation and technology support services in the adult stem cell field. The company was founded in 2005 with capital from Beijing University, Hong Kong University of Science and Technology and Shenzhen City Hall, with additional support from China State National Fund grants.
Shenzhen Beike BioTech's Articles
-
Citation: Stem Cell Research & Therapy 2022 13:65
-
Human umbilical cord-derived mesenchymal stem cells improve the function of liver in rats with acute-on-chronic liver failure via downregulating Notch and Stat1/Stat3 signaling
Citation: Stem Cell Research & Therapy 2021 12:396 -
Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis
Citation: Stem Cell Research & Therapy 2016 7:63 -
Comparison of biological characteristics of mesenchymal stem cells derived from maternal-origin placenta and Wharton’s jelly
Citation: Stem Cell Research & Therapy 2015 6:228 -
Intracoronary infusion of Wharton’s jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial
Citation: BMC Medicine 2015 13:162 -
Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study
Citation: Arthritis Research & Therapy 2014 16:R79 -
Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism
Citation: Journal of Translational Medicine 2013 11:196 -
Human cord blood-derived mononuclear cell transplantation for viral encephalitis-associated cognitive impairment: a case report
Citation: Journal of Medical Case Reports 2013 7:181 -
Quantitative assessment of gait and neurochemical correlation in a classical murine model of Parkinson’s disease
Citation: BMC Neuroscience 2012 13:142 -
Human umbilical cord blood-derived mononuclear cell transplantation: case series of 30 subjects with Hereditary Ataxia
Citation: Journal of Translational Medicine 2011 9:65 -
Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions
Citation: Journal of Translational Medicine 2010 8:75